A Phase 3 interventional study of Tru Vu tool and training in Trauma (Including Fractures) and Arthritis, sponsored by Western University. Not yet recruiting at 3 sites in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-18.
Sponsored by Western University · Phase 3, Interventional, and Other
This study has two primary aims: 1) to determine whether a novel wrist x-ray positioning aid can be implemented within 3 different healthcare centers in Newfoundland and Labrador, and 2) to determine the ability of the tool to improve patient positioning in wrist x-rays. It will also learn about the number of repeat x-rays required with or without the use of the tool and radiographer confidence. The main questions it aims to answer are:
Researchers will compare x-rays before and after the implementation of the tool as well as between centers.
Technologist participants will:
2,217 studies on the registry are indexed under Wounds and Injuries; 441 are open to participants now.
This study's planned enrollment of 1,800 is above the median of 70 across 1,424 interventional studies indexed under Wounds and Injuries.
Browse Wounds and Injuries studies →Western University is the lead sponsor of 14 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Radiographs will be retrospectively collected and compared to radiographs captured after the implementation of the tool. Additional radiographs will be collected over a 6-month follow-up period.
Device: Tru Vu tool and training
Radiographs will be retrospectively collected and compared to radiographs captured after the implementation of the tool. Additional radiographs will be collected over a 6-month follow-up period.
Device: Tru Vu tool and training
Radiographs will be retrospectively collected and compared to radiographs captured after the implementation of the tool. Additional radiographs will be collected over a 6-month follow-up period.
Device: Tru Vu tool and training
A positioning aid and training videos for wrist x-rays
Radiograph grading score
Radiographs collected retrospectively and prospectively will be graded by a radiologist and radiographer
Time frame: Radiographs will be collected retrospectively 4 months prior to implementation and 6 months prospectively after the implementation of the tool.
Tool adoption (and associated implementation outcomes)
A survey will collect perceived tool use and other perceived implementation outcomes (including fidelity, appropriateness, acceptability, and adoption).
Time frame: The survey will be administered 6 months after the implementation of the tool and training.
Sustainability
Post-follow up survey will be conducted 6 months after the end of the implementation period and will collect perceived tool use.
Time frame: 6 months after the conclusion of the implementation period
Repeated radiographs
Document the number of repeat radiographs captured.
Time frame: Repeat radiographs will be collected and compared 4 months retrospectively prior to implementation and 6 months after the start of implementation.
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jun 2026; primary completion for Feb 2027, 7 months later.
Of 33 non-industry phase 3 interventional studies under Wounds and Injuries, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 55. This study's planned 7 months is below that.
Counting every sponsor, half of 37 studies reached it within 36 months; a quarter within 25 and three quarters within 55.
Wounds and Injuries covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Western University